Jeena Sikho Lifecare Ltd.
₹612.2
18.5 (3.1%)
JSLL Share Price
As on June 12, 2026
SectorNA
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap₹ 7,669 Cr
P/E Ratio225.24
Dividend Yield0.03 %
Trendline Performance
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
Company Information
Market Insights
Open606
High617.7
NSE SymbolJSLL
Close612.2
Low590.5
BSE Symbol544476
Previous Years High/Low
1 Year High849.5
3 Year High849.5
5 Year High849.5
1 Year Low400.25
3 Year Low48.56
5 Year Low14.11
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 600.87 | Bullish |
| 10-DMA | 606.12 | Bullish |
| 20-DMA | 622.6 | Bearish |
| 50-DMA | 653.42 | Bearish |
| 100-DMA | 655.29 | Bearish |
| 200-DMA | 696.12 | Bearish |
Historical Performance
1 Year
42.4%
3 Years
1078.1%
5 Years
N/A
10 Years
N/A
Shareholding Pattern
%
Values Analysis
Loading chart...
Profit & Loss
Below figures are in Rs. Crores
| Particulars | Mar-2023 | Mar-2022 |
|---|---|---|
| Net Sales | 2,048 | 1,466 |
| Total Expenditure | 1,589 | 1,285 |
| Other Income | 26 | 15 |
| Operating Profit | 484 | 196 |
| Interest | 9 | 12 |
| Depreciation | 32 | 33 |
| Profit Before Tax | 443 | 151 |
| Consolidated Net Profit | 338 | 112 |
| Adjusted EPS | 3 | 1 |
Compounded Sales Growth
10 Years:6.9
5 Years:6.9
3 Years:6.9
TTM:6.9
Compounded Profit Growth
10 Years:24.6
5 Years:24.6
3 Years:24.6
TTM:24.6
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:128.8
TTM:44.5
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:2.7
Quarterly Results
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2023 | Mar-2022 |
|---|---|---|
| Share Capital | 138 | 101 |
| Total Reserves | 1,120 | 264 |
| Long-Term Borrowings | --- | --- |
| Total Non-Current Liabilities | 2 | 12 |
| Other Current Liabilities | 139 | 119 |
| Short Term Borrowings | --- | 64 |
| Total Liabilities | 1,506 | 615 |
| Capital Work in Progress | 11 | 50 |
| Long Term Loans & Advances | 122 | 64 |
| Currents Investments | 45 | --- |
| Short Term Loans and Advances | 131 | 32 |
| Total Current Assets | 775 | 215 |
| Total Assets | 1,506 | 615 |
| Adjusted Book Value | 10 | 4 |
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
- The stock has a high PE of 225.24, indicating expensive valuation or elevated growth expectations.
- Over the last three years, the stock delivered a strong 3-year price CAGR of 128.9%, indicating sustained price appreciation.
- The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
- In the last financial year, the company reported an EBITDA of ₹484 million, reflecting positive operating performance.
- In the previous financial year, the company generated revenue of ₹2048 million, suggesting a mid-sized operation.
Investment Calculator
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1444208.5
No. of Shares: 2359 (Approx)
Performance:44.4%
P/L: ₹444208.5
NIFTY Performance: -4.4%
1 day Top Gainers
Top Performing Stocks from the same sector
Get Your Portfolio Reviewed
Latest News
Stay Updated with Our Market Newsletters
